Despite the very low expression of NCRs, we found higher frequencies of NKp30, NKp44, and NKp46 NKT-like cells and increased surface density of NKp46 in our group of treated CML patients. This evidence concerns the gene NCR3 and chronic myelogenous leukemia, BCR-ABL1 positive.